PYLARIFY
NDC 71258-022, PIFLUFOLASTAT F-18, injection, from Progenics Pharmaceuticals, Inc..
- Product NDC
- 71258-022
- Status
- Listed
- Labeler
- Progenics Pharmaceuticals, Inc.
- Dosage form
- INJECTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA214793
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/71258-022 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- PIFLUFOLASTAT F-1880 mCi/mL
Pharmacologic classes
Positron Emitting Activity [MoA]; Radioactive Diagnostic Agent [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 71258-022-01 | 71258002201 | 50 mL in 1 VIAL, MULTI-DOSE (71258-022-01) |
Linked data
RxNorm, label and prices
RxNorm concepts
RxNorm links no concept to this product's packages.
Related lookups
FDA label sections
GET /v1/drugs/labels/a00e5cbc-4fd5-4280-82ec-cd3498df4553
Use it
Look up 71258-022 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/71258-022 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 71258-022. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.